| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Development Officer | Chief Development Officer
1 company
Christopher Yea is Chief Development Officer at KALV. From November 2016 to November 2025, the filings on record show 0 open-market purchases and 38 sales. Christopher Yea's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $6.0M at current prices.
Historically, Christopher Yea's trades have earned a middling insider score of 53/100 across 27 rated trades. Over a 12-month horizon, 28.6% of those trades were profitable, with an average 12-month return of -21.6%.
The KALV filings lean toward selling, a net 238,603 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 16, 2020 | KALV Kalvista Pharmaceuticals, Inc. | Chief Development Officer | Sell | 914 | $17.00 | $15,539.28 | -1.1% | |
| Feb 5, 2020 | KALV Kalvista Pharmaceuticals, Inc. | Chief Development Officer | Sell | 100 | $17.10 | $1,710.00 | -0.1% | |
| Dec 20, 2019 | KALV Kalvista Pharmaceuticals, Inc. | Chief Development Officer | Sale+OE | 2,646 | $17.02 | $45,025.13 | -3.1% | |
| Dec 16, 2019 | KALV Kalvista Pharmaceuticals, Inc. | Chief Development Officer | Sale+OE | 4,709 | $17.05 | $80,269.34 | -5.4% | |
| Jul 22, 2019 | KALV Kalvista Pharmaceuticals, Inc. | Chief Development Officer | Sale+OE | 7,355 | $18.35 | $134,929.68 | -8.1% | |
| Apr 22, 2019 | KALV Kalvista Pharmaceuticals, Inc. | Chief Development Officer | Sale+OE | 7,355 | $26.04 | $191,529.84 | -8.1% | |
| Jan 25, 2019 | KALV Kalvista Pharmaceuticals, Inc. | Chief Development Officer | Sale+OE | 5,453 | $17.06 | $93,015.09 | -6.2% | |
| Jan 23, 2019 | KALV Kalvista Pharmaceuticals, Inc. | Chief Development Officer | Sale+OE | 1,902 | $17.01 | $32,343.93 | -2.2% |